Follow
Jeffrey A Cohen
Title
Cited by
Cited by
Year
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
CH Polman, SC Reingold, B Banwell, M Clanet, JA Cohen, M Filippi, ...
Annals of neurology 69 (2), 292-302, 2011
96912011
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina, C Von Kalle, M Schmidt, MP McCormack, ...
science 302 (5644), 415-419, 2003
41282003
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision …
Age-Related Eye Disease Study Research Group
Archives of ophthalmology 119 (10), 1417-1436, 2001
3765*2001
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ...
The Lancet Neurology 17 (2), 162-173, 2018
37632018
Defining the clinical course of multiple sclerosis: the 2013 revisions
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
26522014
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
JA Cohen, F Barkhof, G Comi, HP Hartung, BO Khatri, X Montalban, ...
New England Journal of Medicine 362 (5), 402-415, 2010
25172010
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis: results of a phase III multicenter, double‐blind, placebo‐controlled trial
KP Johnson, BR Brooks, JA Cohen, CC Ford, J Goldstein, RP Lisak, ...
Neurology 45 (7), 1268-1276, 1995
23801995
Fatigue in multiple sclerosis
LB Krupp, LA Alvarez, NG LaRocca, LC Scheinberg
Archives of neurology 45 (4), 435-437, 1988
1295*1988
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
AJ Coles, CL Twyman, DL Arnold, JA Cohen, C Confavreux, EJ Fox, ...
The lancet 380 (9856), 1829-1839, 2012
10792012
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
JA Cohen, AJ Coles, DL Arnold, C Confavreux, EJ Fox, HP Hartung, ...
The Lancet 380 (9856), 1819-1828, 2012
10792012
Differential diagnosis of suspected multiple sclerosis: a consensus approach
DH Miller, BG Weinshenker, M Filippi, BL Banwell, JA Cohen, ...
Multiple Sclerosis Journal 14 (9), 1157-1174, 2008
8292008
Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging.
V Dousset, RI Grossman, KN Ramer, MD Schnall, LH Young, ...
Radiology 182 (2), 483-491, 1992
8181992
Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic …
V Bril, J England, GM Franklin, M Backonja, J Cohen, D Del Toro, ...
Pm&r 3 (4), 345-352. e21, 2011
7992011
Sympathetic skin response--a method of assessing unmyelinated axon dysfunction in peripheral neuropathies.
BT Shahani, JJ Halperin, PH Boulu, J Cohen
Journal of Neurology, Neurosurgery & Psychiatry 47 (5), 536-542, 1984
7761984
Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability
KP Johnson, BR Brooks, JA Cohen, CC Ford, J Goldstein, RP Lisak, ...
Neurology 50 (3), 701-708, 1998
6941998
Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls
MD Goldman, RA Marrie, JA Cohen
Multiple Sclerosis Journal 14 (3), 383-390, 2008
5902008
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation
DB Weiner, J Liu, JA Cohen, WV Williams, MI Greene
Nature 339 (6221), 230-231, 1989
5641989
Benefit of interferon β-1a on MSFC progression in secondary progressive MS
JA Cohen, GR Cutter, JS Fischer, AD Goodman, FR Heidenreich, ...
Neurology 59 (5), 679-687, 2002
4852002
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review
RA Marrie, S Reingold, J Cohen, O Stuve, M Trojano, PS Sorensen, ...
Multiple Sclerosis Journal 21 (3), 305-317, 2015
4442015
Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia
A Jain, CA Ma, S Liu, M Brown, J Cohen, W Strober
Nature immunology 2 (3), 223-228, 2001
4312001
The system can't perform the operation now. Try again later.
Articles 1–20